Literature DB >> 9041089

Comparison of viscoelastic substances used in phacoemulsification.

W W Hütz1, H B Eckhardt, T Kohnen.   

Abstract

PURPOSE: To evaluate the usefulness of four viscoelastic agents during phacoemulsification: 2% hydroxypropylmethylcellulose (HPMC) (Methocel), 3% sodium hyaluronate with 4% chondroitin sulfate (Viscoat), 1% sodium hyaluronate (Healon), 1.4% sodium hyaluronate (Healon GV).
SETTING: Eye Clinic, Kreiskrankenhaus Bad Hersfeld, Germany.
METHODS: Two hundred patients, divided into four groups of 50 patients, received one of the viscoelastic substances during phacoemulsification and posterior chamber intraocular lens implantation. Patients were followed for 1 month. Visual acuity and intraocular pressure (IOP) were measured. The following were subjectively evaluated for each viscoelastic: corneal findings, anterior chamber reaction, visibility of intraocular structures and retention time during phacoemulsification, space maintaining ability, and removability and ease of injection.
RESULTS: Postoperative IOP and visual acuity were comparable among the four groups. Viscoat tended to trap nuclear fragments and air bubbles during the phacoemulsification procedure, which decreased visibility during surgery. Space maintenance and injection ease were significantly better with Healon and Healon GV.
CONCLUSION: The high molecular weight viscoelastics (Healon and Healon GV) performed better as viscosurgical tool during cataract surgery using phacoemulsification.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9041089     DOI: 10.1016/s0886-3350(96)80198-2

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  8 in total

1.  Intraocular pressure rise after small incision cataract surgery: a randomised intraindividual comparison of two dispersive viscoelastic agents.

Authors:  G Rainer; R Menapace; O Findl; B Kiss; V Petternel; M Georgopoulos; B Schneider
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

2.  Intraocular lens implantation without the use of ophthalmic viscosurgical device.

Authors:  Ugur Unsal; Gonen Baser; Mehmet Soyler
Journal:  Int Ophthalmol       Date:  2016-03-14       Impact factor: 2.031

Review 3.  Impact of Ophthalmic Viscosurgical Devices in Cataract Surgery.

Authors:  Monali S Malvankar-Mehta; Angel Fu; Yasoda Subramanian; Cindy Hutnik
Journal:  J Ophthalmol       Date:  2020-10-20       Impact factor: 1.909

4.  Cochlear perfusion with a viscous fluid.

Authors:  Yi Wang; Elizabeth S Olson
Journal:  Hear Res       Date:  2016-05-21       Impact factor: 3.208

5.  Prefilled syringes and usability of ophthalmic viscosurgical devices.

Authors:  Takuya Shiba; Hiroshi Tsuneoka
Journal:  Clin Ophthalmol       Date:  2014-09-04

6.  Comparison of surgical time and IOP spikes with two ophthalmic viscosurgical devices following Visian STAAR (ICL, V4c model) insertion in the immediate postoperative period.

Authors:  Sri Ganesh; Sheetal Brar
Journal:  Clin Ophthalmol       Date:  2016-01-27

7.  Addition Of D-Sorbitol Improves The Usability Of Ophthalmic Viscosurgical Devices.

Authors:  Ippei Watanabe; Mayumi Nagata; Hiroyuki Matsushima
Journal:  Clin Ophthalmol       Date:  2019-09-23

8.  Balanced Salt Solution-Assisted Intraocular Lens Implantation in Phacoemulsification Surgery: Intraocular Pressure and Endothelial Cell Effects.

Authors:  Erdem Yuksel; Baran Ozdemir; Mehmet Ozgur Cubuk
Journal:  Beyoglu Eye J       Date:  2019-02-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.